PMC Group International Announces Copperhead Chemical Company Inc. Receives Northrop Grumman Strategic Excellence Award

14 Mar 2023
www.biospace.com
MOUNT LAUREL, N.J.--(BUSINESS WIRE)-- Copperhead Chemical Company Inc., a subsidiary of PMC Group International, earned Northrop Grumman’s 2022 Strategic Excellence Award as part of their Supplier Excellence Awards. This award distinguishes Copperhead Chemical Company Inc. as a top supplier within Northrop Grumman’s global network of over 10,000 suppliers. This press release features multimedia. View the full release here: “The performance of Copperhead Chemical Company Inc. sets it apart as one of the best of the best supplier partners,” said Matt Bromberg, Corporate Vice President, Global Operations, Northrop Grumman. With over 100 years of experience and a leading manufacturer of energetic materials, Copperhead Chemical Company Inc. is vital to ensuring Northrop Grumman delivers advanced technology solutions with the quality and speed to meet urgent global security challenges. Copperhead Chemical Company products serve diverse end markets, including pharmaceutical, biopharmaceutical, defense, and consumer products. ABOUT PMC PMC Group is a US based growth oriented, diversified, global chemicals and pharmaceuticals company dedicated to innovative solutions to every need in a broad range of end markets including, plastics, consumer products, electronics, coatings, packaging, mining, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation, and marketing platform with facilities in the Americas, Europe, and Asia. More information about PMC Group and its activities around the world can be found at . View source version on businesswire.com: Contacts Jane Potts 856-533-1890 jane.potts@pmc-group.com Source: PMC Group View this news release online at:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.